Efficient polymeric gene vector for in vivo gene delivery
A biodegradable cationic polymeric gene vector designed for in vivo gene delivery, offering high transfection efficiency, low toxicity, and targeted gene delivery to specific organs, overcoming limitations of viral and lipid-based vectors.
Overview
This innovative technology presents a biodegradable cationic polymeric gene vector designed for efficient in vivo gene delivery. The vector addresses the limitations of viral vectors, which pose immunological risks, and lipid-based vectors, which often suffer from reduced in vivo transfection efficiency. By leveraging a well-designed polymeric platform, this solution enhances gene packaging ability, ensures good stability and circulation time, and maintains considerable in vivo transfection efficacy. It aims to make gene therapy more clinically viable by improving therapeutic outcomes while reducing economic burdens on patients.
Technical specifications
Key features:
- Biodegradable and biocompatible: Ensures safe application with minimal toxicity.
- Enhanced gene packaging: Capable of packaging large genes (up to 12 k base pairs) that traditional vectors cannot handle.
- Customizable design: Utilizes hyperbranched cationic polymers with variable chain lengths for optimal gene delivery.
- Targeted delivery: Features functional groups for organ/tissue-specific gene delivery.
- Enhanced transfection: Chemical attachment of enhancers like small molecules, peptides, or antibodies boosts efficiency.
Technology readiness level
The polymeric gene vector is at TRL 4, having demonstrated in vitro transfection efficiency and preliminary in vivo evaluations in mouse models. Future steps include optimizing polymer designs and conducting extensive in vivo tests to further validate efficacy and safety.
About University of Michigan
The University of Michigan is a comprehensive public research university based in Ann Arbor with additional campuses in Dearborn and Flint, known for a broad, interdisciplinary research enterprise and a major academic health system. Industry partners engage through co-located facilities, including a large north campus research complex with shared labs and incubator space, plus on-campus testbeds for rapid prototyping and validation. Proximity to Detroit’s mobility and manufacturing base, plus dedicated business engagement teams, streamlines sponsored research and access to talent. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD, alongside state and industry sponsorship. A centralized tech transfer office manages IP, licensing, and startup support, with corporate memberships and flexible agreements.
delivered to your inbox.